Resistance of Pancreatic Carcinoma Cells Is Reversed by Coculturing NK-like T Cells with Dendritic Cells Pulsed with Tumor-Derived RNA and CA 19-9-Reference-Cited by-同舟云学术

Resistance of Pancreatic Carcinoma Cells Is Reversed by Coculturing NK-like T Cells with Dendritic Cells Pulsed with Tumor-Derived RNA and CA 19-9

Published:2001-01 Issue:1 Volume:3 Page:54-60
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Ziske Carsten,Märten Angela,Schöttker Björn,Buttgereit Peter,Schakowski Frank,Gorschlüter Markus,von Rücker Alexander,Scheffold Christian,Chao Nelson,Sauerbruch Tilman,Schmidt-Wolf Ingo G.H.

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference31 articles.

1. Resistance of different tumor cells to lysis by lymphokine activated killer cells can be mediated by distinct mechanisms;Bean;Immunobiology,1992

2. Increase of the immunostimulatory effect of dendritic cells by pulsing with CA 19-9 protein;Märten;J. Immunother.,2000

3. Dendritic cells and the control of immunity;Banchereau;Nature,1998

4. Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells;Nestle;Nat. Med.,1998

5. Induction of virus-specific cytotoxic T lymphocytes in vivo by liposome-entrapped mRNA;Martinon;Eur. J. Immunol.,1993

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of Biofunctionalized Nanoparticles in Digestive Cancer Vaccine Development;Pharmaceutics;2024-03-16

2. Combining cellular immunotherapy was an optional choice for unresectable advanced HCC: A systematic review and meta-analysis;Clinics and Research in Hepatology and Gastroenterology;2021-01

3. Increased cycles of DC/CIK immunotherapy decreases frequency of Tregs in patients with resected NSCLC;International Immunopharmacology;2017-11

4. A systems biology approach to investigating the influence of exercise and fitness on the composition of leukocytes in peripheral blood;Journal for ImmunoTherapy of Cancer;2017-04-18

5. Combined immunotherapy with dendritic cells and cytokine-induced killer cells for malignant tumors: A systematic review and meta-analysis;International Immunopharmacology;2014-10